We are live on
!
Find out more
iBio
IBIO
IBIO
13 hedge funds and large institutions have $275K invested in iBio in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
30% more funds holding
Funds holding: 10 → 13 (+3)
0% less ownership
Funds ownership: 0.01% → 0% (-0%)
30% less capital invested
Capital invested by funds: $393K → $275K (-$118K)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Holders
13
Holders Change
+3
Holders Change %
+30%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TSS
Two Sigma Securities
New York
|
+$15.4K |
| 2 |
VF
Virtu Financial
New York
|
+$8.1K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$2.02K |
| 4 |
BlackRock
New York
|
+$405 |
Top Sellers
| 1 |
S
SignatureFD
Atlanta,
Georgia
|
-$111K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$4.45K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.02K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$405 |